DAFTAR PUSTAKA 1. World Health Organization. Comprehensive Cervical Cancer Control. A Guide to Essential Practice. Geneva : WHO; 2006. 2. Rasjidi Imam. Manual Prakanker Serviks. 1st ed. Jakarta: Sagung Seto; 2008. 3. Tjindarbumi D, Mangunkusumo R. Cancer in Indonesia, Present and Future. Jpn J Clin Oncol 2002; 32:17-21. 4. Suwiyoga IK. Tes Human Papillomavirus sebagai skrining alternative kanker serviks. CDK 2006; 151: 29-33. 5. Cornain S.
Further Development of Cervical Cancer Screening and
Anticipation of HPV vaccination in Indonesia. Final Report.
Faculty of
Medicine, University of Indonesia, Female Cancer Programme LUMCIndonesia, National Committee for Cancer Control Program; 2009. 6. Cornain S. Sustainable Development of Cervical Cancer Screening by "See and Treat" Approach in Indonesia. Final Report. Coordinating Board for Female Cancer Programme-Indonesia; 2009. 7. Saslow D, Runowicz CD, Solomon D, Moscicki AB, Smith RA, Eyre HJ, et al. American Cancer Society Guideline for the Early Detection of Cervical Neoplasia and Cancer. CA Cancer J Clin 2002; 52:342. 8. Sankaranarayanan R, Budukh AM Rajkumar R.
Effective Screening
programmes for cervical cancer in low and middle-income developing countries. Bull of WHO 2001; 79:954-62. 9. Coleman M. Time trends in cancer incidence, mortality, and prevalence worldwide. IARC; 1995. 10. Wabinga HR, Parkin DM, Mangen FW, Nambooze S. Trends in cancer incidence in Kyadondo country, Uganda, 1860-1997. Br J Cancer 2000; 82:585-92.
49
Analisa faktor..., Lestari Mustika Rini, FK UI, 2009
Universitas Indonesia
50
11. University of Zimbabwe/JHPIEGO Cervical Cancer Project.
Visual
inspection with acetic acid for cervical cancer screening: Test qualities in a primary care setting. Lancet 1999; 353:869-73. 12. Gupta S, Sodhani P, Halder K, Chachra KL, Singh V, Sehgal A. Age trends in pre-cancerous and cancerous lesions of the uterine cervix in a cytology screening programme: what should be the target age group for a major thrust of screening in resource-limited settings?. Cytopathology 2008; 19:106-10. 13. Aziz MF. Gynecological cancer in Indonesia. J Gynecol Oncol 2009; 1:810. 14. Mardjikoen P. Tumor ganas alat genital. In: Wiknjosastro H, Saifuddin AB, Rachimhadhi T, editor. Ilmu kandungan. 2nd ed. Jakarta : Yayasan Bina Pustaka Sarwono Prawirohardjo 2007.p.380. 15. Nurbaiti.
Kanker Rahim.
Available
from:
URL:
2009 Feb [cited 2009 Jun 10]; 1:[2 screen]. http://ilmupedia.com/akademik/92/649-kanker-
rahim.pdf 16. Anonim. Kanker Leher Rahim. 2006 [cited 2009 Jun 10]. Available form: URL: http://medicastore.com/penyakit/1046/Kanker_Leher_Rahim_Kanker_Serviks .html 17. Garcia AA. Cervical Cancer. 2007 [cited 2009 Jun 10]. Available form: URL: http://emedicine.medscape.com/article/253513-overview 18. Aziz F, Nugroho K, Ratna S S. Karsinoma serviks Uterus. Bagian / SMF Obstetri
dan
Ginekologi
Fakultas
Kedokteran
UI
-
RS
dr.
Ciptomangunkusumo Jakarta; 1985. 19. Cervical Cancer Campaign. Understanding Cervical Cancer, A Woman’s Guide. Chicago: Ginecologic Cancer Foundation; 2006. 20. Departemen Kesehatan Republik Indonesia. Penanggulangan Kanker Serviks dengan Vaksin HPV. Jakarta : DEPKES RI; 2005.
Universitas Indonesia
Analisa faktor..., Lestari Mustika Rini, FK UI, 2009
51
21. Putri, Henny.
Manajemen Karsinoma Serviks, Referat. Bagian / SMF
Obstetri dan Ginekologi Fakultas Kedokteran UGM - RS dr. Sardjito Yogyakarta; 2009. 22. Aziz MF. Masalah pada Kanker Serviks. CDK 2001; 133:6. 23. Female Cancer Program Foundation. Indonesia: Mutual Enthusiasm About Working Together.
[cited 2009 Jun 10].
Available form: URL:
http://www.femalecancerprogram.org/FCP/whoareourpartners/Indonesia/defa ult. 24. Cullati S, Charvet-Bérard AI, Perneger TV. Cancer screening in a middle-
aged general population: factors associated with practices and attitudes. BMC Public Health 2009; 9:118. 25. Anonim. What Are The Risk Factors For Cervical Cancer?. 2009 [cited 2009 Jun 10]. Available form: URL: http://www.cancer.org/docroot/CRI/content/CRI_2_4_2X_What_are_the_risk _factors_for_cervical_cancer_8.asp 26. Mardjikoen P. Tumor ganas alat genital. In: Wiknjosastro H, Saifuddin AB, Rachimhadhi T, editor. Ilmu kandungan. 2nd ed. Jakarta : Yayasan Bina Pustaka Sarwono Prawirohardjo 2007.p.381-3. 27. Morrow CP, Curtin JP, Townsend DE. Synopsis of Gynecologic Oncology. New York: Churchill Livingstone; 1987. 28. Goodman HM, Nelson JH. Cervical malignancies. In : Knaap KC, Berkowitz Gynaecology Oncology.
RS eds.
New York: Macmillan Publ Co
1986.p.225-65. 29. Krivak TC, McBroom JW, Elkas JC. Cervical and vaginal cancer. In: Berek JS, Adashi EY, Hillard PA, eds. Novak's ginecology. 13th ed. Lippincot Williams & Wilkin. Baltimore 2002.p.1199-244. 30. Benedet JL, Ngan HYS, Hacker NF. Staging Classifications and clinical practice guidelines of gynecologyc cancers. Int J Gynecol Cancer 2000; 70:207-312.
Universitas Indonesia
Analisa faktor..., Lestari Mustika Rini, FK UI, 2009
52
31. Andrijono.
Kanker Serviks. Divisi Onkologi, Dep.Obstetri-Ginekologi
FKUI; 2007. 32. Boon ME, Suurmeijer AJH. The Pap smear. Leiden: Coulomb Press; 1991. 33. Pretoriun R, Semrad N Watring W Fotherongham N. Presentation of cervical cancer. Gynecol Oncol 1991; 42: 48-52. 34. Nuranna, L. Penanggulangan Kanker Serviks yang Sahih dan Andal dengan metode Proaktif-VO (Proaktif, koordinatif dengan skrining IVA dan terapi krio). Desertasi Program Doktor. Jakarta: FKUI; 2005. 35. Kitchener HC, Symonds P. Detection of cervical intraepithelial neoplasia in developing countries. Lancet 1999; 353.p.856-857. 36. Sjamsuddin S. Pencegahan dan deteksi dini kanker serviks. CDK 2001; 133:8. 37. Petignat P, Roy M. Diagnosis and management of cervical cancer. Br Med J 2007; 335:765-8. 38. Legra TL, Guerreiro TC. Prevalence and Risk Factors In Positive Cervix Cytology.
2004 [cited 2009 Jun 10].
Available form: URL:
http://www.medicc.org/publications/medicc_review/1004/pdfs/Cuban%20Me dical%20Literature_3.pdf 39. Female Cancer Program Foundation. Who Are Our Partners. [cited 2009 Jun 10]. Available form: URL: http://www.femalecancerprogram.org/FCP/whoareourpartners/default/default 40. F.Gary Cunningham. William Obstetrics. 22nd ed. USA: McGraw-Hill Companies; 2005. 41. Putra AD, Moegni EM. Lesi Prakanker Serviks. In: Aziz MF, Andrijono, Saifuddin AB. Onkologi Ginekologi. 1st ed. Jakarta: Yayasan Bina Pustaka Sarwono Prawirohardjo; 2006.p.399-400. 42. Rückinger S, Tauscher M, Redel R, Munte A, Walchner-Bonjean M, Hess J, Schneider A, von Kries R. Participation in cervical cancer screening by age and region--a cohort study with a 3 1/2 year follow-up on 2,223,135 women in Bavaria. Gesundheitswesen 2008;70:17-21.
Universitas Indonesia
Analisa faktor..., Lestari Mustika Rini, FK UI, 2009
53
43. Akýn B, Ege E, Koçoðlu D, Arslan SY, Bilgili N. Reproductive history, socioeconomic status and disability in the woman aged 65 years or older in Turkey. Arch Gerontol Geriatr 2009. 44. Amrantara A.
Analisa Usia Pertama Kali Menikah pada Wanita Peserta
Program Penapisan Kanker Leher Rahim Dengan Pendekatan "See & Treat" : Untuk Deteksi Lesi Prakanker dan Pengobatan Dengan Terapi Beku. Final Report. FKUI 2009. 45. Hakim A.
Analisa Jumlah Melahirkan pada Wanita Peserta Program
Penapisan Kanker Leher Rahim Dengan Pendekatan "See & Treat" : Untuk Deteksi Lesi Prakanker dan Pengobatan Dengan Terapi Beku. Final Report. FKUI 2009. 46. Ginealdy W.
Analisa Faktor Riwayat Kontrasepsi pada Wanita Peserta
Program Penapisan Kanker Leher Rahim Dengan Pendekatan "See & Treat" : Untuk Deteksi Lesi Prakanker dan Pengobatan Dengan Terapi Beku. Final Report. FKUI 2009. 47. Lembahmanah L. Analisa Faktor Tingkat Pendidikan pada Wanita Peserta Program Penapisan Kanker Leher Rahim Dengan Pendekatan "See & Treat" : Untuk Deteksi Lesi Prakanker dan Pengobatan Dengan Terapi Beku. Final Report. FKUI 2009. 48. Pasaribu AT.
Analisa Riwayat Kanker pada Wanita Peserta Program
Penapisan Kanker Leher Rahim Dengan Pendekatan "See & Treat" : Untuk Deteksi Lesi Prakanker dan Pengobatan Dengan Terapi Beku. Final Report. FKUI 2009.
Universitas Indonesia
Analisa faktor..., Lestari Mustika Rini, FK UI, 2009
